Follow
Francesco Giganti
Francesco Giganti
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
28502018
Automatic multi-organ segmentation on abdominal CT with dense V-networks
E Gibson, F Giganti, Y Hu, E Bonmati, S Bandula, K Gurusamy, ...
IEEE transactions on medical imaging 37 (8), 1822-1834, 2018
6772018
Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review
IG Schoots, N Petrides, F Giganti, LP Bokhorst, A Rannikko, L Klotz, ...
European urology 67 (4), 627-636, 2015
3792015
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
A Stabile, F Giganti, AB Rosenkrantz, SS Taneja, G Villeirs, IS Gill, C Allen, ...
Nature reviews urology 17 (1), 41-61, 2020
3122020
Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study
D Dong, MJ Fang, L Tang, XH Shan, JB Gao, F Giganti, RP Wang, X Chen, ...
Annals of oncology 31 (7), 912-920, 2020
2562020
Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force
CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ...
European urology 71 (4), 648-655, 2017
2492017
ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation†…
M de Rooij, B IsraŽl, M Tummers, HU Ahmed, T Barrett, F Giganti, ...
European radiology 30, 5404-5416, 2020
2262020
Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial
F Giganti, C Allen, M Emberton, CM Moore, V Kasivisvanathan, ...
European urology oncology 3 (5), 615-619, 2020
2112020
Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis
V Kasivisvanathan, A Stabile, JB Neves, F Giganti, M Valerio, ...
European urology 76 (3), 284-303, 2019
2052019
National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection–recommendations from a UK consensus meeting
M Brizmohun Appayya, J Adshead, HU Ahmed, C Allen, A Bainbridge, ...
BJU international 122 (1), 13-25, 2018
1392018
Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology
F De Cobelli, F Giganti, E Orsenigo, M Cellina, A Esposito, G Agostini, ...
European radiology 23, 2165-2174, 2013
1292013
Five-year outcomes of magnetic resonance imaging–based active surveillance for prostate cancer: a large cohort study
V Stavrinides, F Giganti, B Trock, S Punwani, C Allen, A Kirkham, ...
European urology 78 (3), 443-451, 2020
1252020
Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary localized prostate†…
A Stabile, C Orczyk, F Hosking‐Jervis, F Giganti, M Arya, RG Hindley, ...
BJU international 124 (3), 431-440, 2019
1242019
Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker
F Giganti, S Antunes, A Salerno, A Ambrosi, P Marra, R Nicoletti, ...
European radiology 27, 1831-1839, 2017
1132017
Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review
A Stabile, F Giganti, V Kasivisvanathan, G Giannarini, CM Moore, ...
European urology oncology 3 (2), 145-167, 2020
1032020
Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy†…
F De Cobelli, S Ravelli, A Esposito, F Giganti, A Gallina, F Montorsi, ...
American Journal of Roentgenology 204 (3), 550-557, 2015
982015
An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines
V Panebianco, F Giganti, YX Kitzing, F Cornud, R Campa, G De Rubeis, ...
Insights into imaging 9, 87-101, 2018
972018
Is magnetic resonance imaging‐targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low‐risk prostate cancer? A systematic†…
IG Schoots, D Nieboer, F Giganti, CM Moore, CH Bangma, MJ Roobol
BJU international 122 (6), 946-958, 2018
882018
Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists
M Antonelli, EW Johnston, N Dikaios, KK Cheung, HS Sidhu, MB Appayya, ...
European radiology 29, 4754-4764, 2019
772019
VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient
EW Johnston, E Bonet-Carne, U Ferizi, B Yvernault, H Pye, D Patel, ...
Radiology 291 (2), 391-397, 2019
772019
The system can't perform the operation now. Try again later.
Articles 1–20